Metformin is a biguanide antihyperglycemic agent used for treating non-insulin-dependent diabetes mellitus (NIDDM). It is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Limited evidence suggests metformin may prevent the cardiovascular disease and cancer complications of diabetes. It improves glycemic control by decreasing hepatic glucose production, decreasing glucose absorption and increasing insulin-mediated glucose uptake. Metformin may induce weight loss and is the drug of choice for obese NIDDM patients. Use of metformin is associated with modest weight loss.
Mechanism of Action of Metformin
Metformin’s mechanisms of action differ from other classes of oral antihyperglycemic agents. Metformin decreases blood glucose levels by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. These effects are mediated by the initial activation by metformin of AMP-activated protein kinase (AMPK), a liver enzyme that plays an important role in insulin signaling, whole body energy balance, and the metabolism of glucose and fats. Activation of AMPK is required for metformin’s inhibitory effect on the production of glucose by liver cells. Increased peripheral utilization of glucose may be due to improved insulin binding to insulin receptors. Metformin administration also increases AMPK activity in skeletal muscle. AMPK is known to cause GLUT4 deployment to the plasma membrane, resulting in insulin-independent glucose uptake. The rare side effect, lactic acidosis, is thought to be caused by the decreased liver uptake of serum lactate, one of the substrates of gluconeogenesis. In those with healthy renal function, the slight excess is simply cleared. However, those with a severe renal impairment may accumulate clinically significant serum lactic acid levels. Other conditions that may precipitate lactic acidosis include severe hepatic disease and acute/decompensated heart failure.
Indications of Metformin
- Diabetes, Type 2
- Polycystic Ovary Syndrome
- Diabetes, Type 3c
- Insulin Resistance Syndrome
- Female Infertility
- For use as an adjunct to diet and exercise in adult patients (18 years and older) with NIDDM. May also be used for the management of metabolic and reproductive abnormalities associated with polycystic ovary syndrome (PCOS). Jentadueto is for the treatment of patients when both linagliptin and metformin is appropriate.
Dosage of Metformin
- Strengths: 500 mg; 750 mg; 850 mg; 1000 mg; 500 mg/5 mL
Diabetes Type 2
Immediate-release
- Initial dose: 500 mg orally twice a day or 850 mg orally once a day
- Dose titration: Increase in 500 mg weekly increments or 850 mg every 2 weeks as tolerated
- Maintenance dose: 2000 mg daily in divided doses
- Maximum dose: 2550 mg/day
Extended-release
- Initial dose: 500 to 1000 mg orally once a day
- Dose titration: Increase in 500 mg weekly increments as tolerated
- Maintenance dose: 2000 mg daily
- Maximum dose: 2500 mg daily
Pediatric Diabetes Type 2
10 years or older
Immediate-release
- Initial dose: 500 mg orally twice a day
- Dose titration: Increase in 500 mg weekly increments as tolerated
- Maintenance dose: 2000 mg daily
- Maximum dose: 2000 mg daily
Side Effects of Metformin
Most common
- physical weakness (asthenia)
- diarrhea
- gas (flatulence)
- symptoms of weakness, muscle pain (myalgia)
- upper respiratory tract infection
- low blood sugar (hypoglycemia)
- abdominal pain (GI complaints), lactic acidosis (rare)
- low blood levels of vitamin B-12
- nausea,vomiting
- chest discomfort
- chills, dizziness
- bloating/abdominal distention
- constipation
- heartburn
More common
- Abdominal or stomach discomfort
- cough or hoarseness
- decreased appetite
- diarrhea
- fast or shallow breathing
- fever or chills
- general feeling of discomfort
- lower back or side pain
- muscle pain or cramping
- painful or difficult urination
Less common
- Abnormal stools
- bad, unusual, or unpleasant (after) taste
- change in taste
- difficulty with moving
- discoloration of the fingernails or toenails
- flu-like symptoms
- joint pain
- rash
- runny nose
- sneezing
- stuffy nose
- swollen joints
Drug Interactions of Metformin
Metformin may interact with following drugs, supplements & may decrease the efficacy of the drug
- angiotensin converting enzyme inhibitors (ACEIs; captopril, enalapril, ramipril)
- alcohol
- antipsychotic medications (e.g., chlorpromazine, haloperidol, olanzapine,
- birth control pills
- bupropion
- corticosteroids (e.g., dexamethasone, prednisone)
- diabetic drugs (e.g., glyburide, insulin, repaglinide, sitagliptin)
- diuretics (e.g., furosemide, hydrochlorothiazide)
- HIV protease inhibitors (e.g., atazanavir, indinavir, ritonavir, saquinavir)
- phenytoin
- quinolone antibiotics (e.g., levofloxacin, moxifloxacin)
- selective serotonin reuptake inhibitors (SSRIs; citalopram, fluoxetine, sertraline paroxetine,
- trimethoprim
- vancomycin
- verapamil
- warfarin
Pregnancy & Lactation of Metformin
FDA Pregnancy Category B
Pregnancy
This medication should not be used during pregnancy. If you become pregnant while taking this medication, contact your doctor immediately.
Lactation
Metformin is believed to pass into breast milk. This medication should not be used if you are breastfeeding.
References
About the author